Trials / Conditions / Refractory Status Epilepticus

Refractory Status Epilepticus

9 registered clinical trials studyying Refractory Status Epilepticus — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Ketamine for the Treatment of Refractory Status Epilepticus NCT07177235	Thomas Jefferson University	Phase 4
Terminated	Efficacy and Safety of Perampanel in the Treatment of Refractory Status Epilepticus NCT05684978	Wayne State University	Phase 4
Completed	Multicenter Retrospective Study of Isoflurane in Refractory and Super-Refractory Status Epilepticus NCT05830864	Hopital of Melun	—
Recruiting	Application of tDCS Stimulation in Controlling Refractory Status Epilepticus NCT06344338	Xuanwu Hospital, Beijing	N/A
Withdrawn	To Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ganaxolone Added to Standard of Care in Refr NCT05814523	Marinus Pharmaceuticals	Phase 3
Terminated	Feasibility Study: tDCS for Treatment of Refractory Status Epilepticus NCT05934903	Yale University	N/A
Recruiting	buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest NCT05851391	University of California, San Francisco	Phase 2
Completed	Refractory Status Epilepticus Treatment: Quality and Efficacy of Coma Induction NCT04333082	University Hospital, Basel, Switzerland	—
Completed	Ketogenic Diet for Refractory Status Epilepticus NCT01796574	Johns Hopkins University	N/A